MetaVia (MTVA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.26, -8.03% vs the prior close of $1.37.
- Volume 75.72K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MTVA slides 8.0% to $1.26, a 3-month low. Closed at $1.26, -8.03% vs the prior close of $1.37. Day range $1.26–$1.43, opened at $1.38.
MTVA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MTVA slides 8.0% to $1.26, a 3-month low
- Closed at $1.26, -8.03% vs the prior close of $1.37. Day range $1.26–$1.43, opened at $1.38.
- Volume was 75.72K shares, 0.9x its 50-day average of 80.53K.
- Price is -19.7% vs its 50-day average ($1.57) and -37.7% vs its 200-day average ($2.02).
- 52-week range $0.97–$14.85; today's close sits at 2% of that range, 91.5% below the 52-week high.
Oct 15, 2026 — MTVA rises 0.7% to $1.37
- Closed at $1.37, +0.74% vs the prior close of $1.36. Day range $1.33–$1.44, opened at $1.35.
- Volume was 50.10K shares, 0.6x its 50-day average of 80.46K.
- Price is -12.9% vs its 50-day average ($1.57) and -33.5% vs its 200-day average ($2.06).
- 52-week range $0.97–$14.85; today's close sits at 3% of that range, 90.8% below the 52-week high.
Oct 14, 2026 — MTVA slides 4.9% to $1.36
- Closed at $1.36, -4.90% vs the prior close of $1.43. Day range $1.35–$1.43, opened at $1.40.
- Volume was 40.50K shares, 0.5x its 50-day average of 80.93K — lighter than usual.
- Price is -13.6% vs its 50-day average ($1.57) and -35.1% vs its 200-day average ($2.10).
- 52-week range $0.97–$14.85; today's close sits at 3% of that range, 90.8% below the 52-week high.
Oct 13, 2026 — MTVA dips 1.4% to $1.43
- Closed at $1.43, -1.38% vs the prior close of $1.45. Day range $1.41–$1.52, opened at $1.52.
- Volume was 65.40K shares, 0.8x its 50-day average of 80.33K.
- Price is -9.3% vs its 50-day average ($1.58) and -33.1% vs its 200-day average ($2.14).
- 52-week range $0.97–$14.85; today's close sits at 3% of that range, 90.4% below the 52-week high.
- SEC filings that day: 8-K.
Oct 12, 2026 — MTVA rises 2.8% to $1.45
- Closed at $1.45, +2.84% vs the prior close of $1.41. Day range $1.41–$1.59, opened at $1.43.
- Volume was 137.00K shares, 1.7x its 50-day average of 80.26K.
- Price is -8.1% vs its 50-day average ($1.58) and -33.4% vs its 200-day average ($2.18).
- 52-week range $0.97–$14.85; today's close sits at 3% of that range, 90.2% below the 52-week high.
Oct 9, 2026 — MTVA jumps 5.2% to $1.41
- Closed at $1.41, +5.22% vs the prior close of $1.34. Day range $1.35–$1.44, opened at $1.35.
- Volume was 49.60K shares, 0.6x its 50-day average of 80.25K.
- Price is -10.6% vs its 50-day average ($1.58) and -36.4% vs its 200-day average ($2.22).
- 52-week range $0.97–$14.85; today's close sits at 3% of that range, 90.5% below the 52-week high.
Oct 8, 2026 — MTVA slides 8.2% to $1.34, a 3-month low, 8 down days in a row
- Closed at $1.34, -8.22% vs the prior close of $1.46. Day range $1.33–$1.48, opened at $1.47.
- Volume was 112.00K shares, 1.4x its 50-day average of 79.10K.
- Price is -15.1% vs its 50-day average ($1.58) and -40.7% vs its 200-day average ($2.26).
- 52-week range $0.97–$14.85; today's close sits at 3% of that range, 91.0% below the 52-week high.
- That makes 8 straight losses.
Oct 7, 2026 — MTVA dips 1.4% to $1.46, a 1-month low, 7 down days in a row
- Closed at $1.46, -1.35% vs the prior close of $1.48. Day range $1.46–$1.52, opened at $1.47.
- Volume was 30.80K shares, 0.4x its 50-day average of 79.58K — lighter than usual.
- Price is -7.6% vs its 50-day average ($1.58) and -36.4% vs its 200-day average ($2.30).
- 52-week range $0.97–$14.85; today's close sits at 4% of that range, 90.2% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — MTVA slides 3.9% to $1.48, a 1-month low, 6 down days in a row
- Closed at $1.48, -3.90% vs the prior close of $1.54. Day range $1.45–$1.54, opened at $1.52.
- Volume was 86.10K shares, 1.1x its 50-day average of 79.78K.
- Price is -6.3% vs its 50-day average ($1.58) and -36.5% vs its 200-day average ($2.33).
- 52-week range $0.97–$14.85; today's close sits at 4% of that range, 90.0% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — MTVA ends flat (+0.0%) to $1.54, 5 down days in a row
- Closed at $1.54, +0.00% vs the prior close of $1.54. Day range $1.54–$1.59, opened at $1.55.
- Volume was 53.10K shares, 0.7x its 50-day average of 80.14K.
- Price is -2.4% vs its 50-day average ($1.58) and -34.8% vs its 200-day average ($2.36).
- 52-week range $0.97–$14.85; today's close sits at 4% of that range, 89.6% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — MTVA ends flat (+0.0%) to $1.54, 4 down days in a row
- Closed at $1.54, +0.00% vs the prior close of $1.54. Day range $1.51–$1.65, opened at $1.56.
- Volume was 61.40K shares, 0.8x its 50-day average of 81.44K.
- Price is -2.4% vs its 50-day average ($1.58) and -35.7% vs its 200-day average ($2.40).
- 52-week range $0.97–$14.85; today's close sits at 4% of that range, 89.6% below the 52-week high.
- That makes 4 straight losses.
MTVA latest news & SEC filings
Every SEC filing by or about MTVA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Browne Sarah Kaplan received an award of 53,000 shares on Oct 12, 2026; now holds 53,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.32M (prior year -$4.00M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.90 (prior year -$2.87) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 2, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade MTVA
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 26, 2026, Jan 5, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.70% (largest 8.2%).
- Liquidity: about 62.05K shares (≈$78.18K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.26 vs a range of $0.97–$14.85 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:11 on Dec 5, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 8-K Sep 9, 2026; 10-Q Aug 6, 2026.
- Share count: 6.59M shares outstanding (Aug 3, 2026), -72.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MTVA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.38 | 1.43 | 1.26 | 1.26 | 75.72K |
| Oct 15, 2026 | 1.35 | 1.44 | 1.33 | 1.37 | 50.10K |
| Oct 14, 2026 | 1.40 | 1.43 | 1.35 | 1.36 | 40.50K |
| Oct 13, 2026 | 1.52 | 1.52 | 1.41 | 1.43 | 65.40K |
| Oct 12, 2026 | 1.43 | 1.59 | 1.41 | 1.45 | 137.00K |
| Oct 9, 2026 | 1.35 | 1.44 | 1.35 | 1.41 | 49.60K |
| Oct 8, 2026 | 1.47 | 1.48 | 1.33 | 1.34 | 112.00K |
| Oct 7, 2026 | 1.47 | 1.52 | 1.46 | 1.46 | 30.80K |
| Oct 6, 2026 | 1.52 | 1.54 | 1.45 | 1.48 | 86.10K |
| Oct 5, 2026 | 1.55 | 1.59 | 1.54 | 1.54 | 53.10K |
| Oct 2, 2026 | 1.56 | 1.65 | 1.51 | 1.54 | 61.40K |
| Oct 1, 2026 | 1.59 | 1.61 | 1.52 | 1.54 | 46.60K |
| Sep 30, 2026 | 1.64 | 1.66 | 1.55 | 1.57 | 65.10K |
| Sep 29, 2026 | 1.64 | 1.67 | 1.61 | 1.66 | 26.10K |
| Sep 28, 2026 | 1.65 | 1.70 | 1.62 | 1.67 | 135.00K |
| Sep 25, 2026 | 1.68 | 1.68 | 1.61 | 1.66 | 28.70K |
| Sep 24, 2026 | 1.66 | 1.66 | 1.61 | 1.63 | 63.60K |
| Sep 23, 2026 | 1.65 | 1.66 | 1.61 | 1.63 | 37.60K |
| Sep 22, 2026 | 1.69 | 1.69 | 1.64 | 1.68 | 31.30K |
| Sep 21, 2026 | 1.65 | 1.70 | 1.64 | 1.67 | 45.30K |
About MetaVia
MetaVia (MTVA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBRIDGE, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1638287.
MTVA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jason L Groves | Director | Jun 8, 2026 |
| Mark A Glickman | Director | Jun 8, 2026 |
| Andrew I Koven | Director | Jun 8, 2026 |
| Hyung Heon Kim | CEO & President | Jan 27, 2026 |
| D Gordon Strickland | Director | Jun 8, 2026 |
| Michael Salsbury | Director | Jun 8, 2026 |
| James Patrick Tursi | Director | Jun 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hyung Heon Kim | CEO & President | Jan 27, 2026 |
| Marshall H Woodworth | Chief Financial Officer | Jan 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MTVA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-12.97M | -7.35 | $-15.70M |
| Dec 31, 2024 | — | $-27.59M | -39.13 | $-24.71M |
| Dec 31, 2023 | — | $-12.47M | -2.46 | $-10.80M |
| Dec 31, 2022 | — | $-13.97M | -43.42 | $-11.71M |
| Dec 31, 2021 | — | $-15.28M | -19.81 | $-15.13M |
Latest balance sheet: total assets $13.27M, total liabilities $6.45M, cash $12.63M (as of Jun 30, 2026).
MTVA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $1.45 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.19 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $1.32 |
| Jan 5, 2026 | 8-K Item 2.02 (results) | $8.73 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $9.35 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $7.00 |
| May 14, 2025 | 8-K Item 2.02 (results) | $7.34 |
| Mar 20, 2025 | 8-K Item 2.02 (results) | $17.05 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $29.48 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MTVA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.